299 related articles for article (PubMed ID: 3968450)
21. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
[TBL] [Abstract][Full Text] [Related]
22. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.
Harris AM; Bhuiyan MS; Chowdhury F; Khan AI; Hossain A; Kendall EA; Rahman A; LaRocque RC; Wrammert J; Ryan ET; Qadri F; Calderwood SB; Harris JB
Infect Immun; 2009 Sep; 77(9):3850-6. PubMed ID: 19528207
[TBL] [Abstract][Full Text] [Related]
23. Mucosal immunologic responses in cholera patients in Bangladesh.
Uddin T; Harris JB; Bhuiyan TR; Shirin T; Uddin MI; Khan AI; Chowdhury F; LaRocque RC; Alam NH; Ryan ET; Calderwood SB; Qadri F
Clin Vaccine Immunol; 2011 Mar; 18(3):506-12. PubMed ID: 21248157
[TBL] [Abstract][Full Text] [Related]
24. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.
Asaduzzaman M; Ryan ET; John M; Hang L; Khan AI; Faruque AS; Taylor RK; Calderwood SB; Qadri F
Infect Immun; 2004 Aug; 72(8):4448-54. PubMed ID: 15271902
[TBL] [Abstract][Full Text] [Related]
25. Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study.
Wiens KE; Iyer AS; Bhuiyan TR; Lu LL; Cizmeci D; Gorman MJ; Yuan D; Becker RL; Ryan ET; Calderwood SB; LaRocque RC; Chowdhury F; Khan AI; Levine MM; Chen WH; Charles RC; Azman AS; Qadri F; Alter G; Harris JB
Lancet Microbe; 2023 Apr; 4(4):e228-e235. PubMed ID: 36907197
[TBL] [Abstract][Full Text] [Related]
26. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.
Chowdhury F; Khan AI; Harris JB; LaRocque RC; Chowdhury MI; Ryan ET; Faruque AS; Calderwood SB; Qadri F
Pediatr Infect Dis J; 2008 Nov; 27(11):986-92. PubMed ID: 18833030
[TBL] [Abstract][Full Text] [Related]
27. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.
Leung DT; Uddin T; Xu P; Aktar A; Johnson RA; Rahman MA; Alam MM; Bufano MK; Eckhoff G; Wu-Freeman Y; Yu Y; Sultana T; Khanam F; Saha A; Chowdhury F; Khan AI; Charles RC; Larocque RC; Harris JB; Calderwood SB; Kovác P; Qadri F; Ryan ET
Clin Vaccine Immunol; 2013 Jun; 20(6):780-8. PubMed ID: 23515016
[TBL] [Abstract][Full Text] [Related]
28. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.
Clemens JD; van Loon F; Sack DA; Chakraborty J; Rao MR; Ahmed F; Harris JR; Khan MR; Yunus M; Huda S
J Infect Dis; 1991 Jun; 163(6):1235-42. PubMed ID: 2037789
[TBL] [Abstract][Full Text] [Related]
29. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
Yang JS; An SJ; Jang MS; Song M; Han SH
PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
[TBL] [Abstract][Full Text] [Related]
30. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
Jertborn M; Svennerholm AM; Holmgren J
J Clin Microbiol; 1986 Aug; 24(2):203-9. PubMed ID: 3528211
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.
Akhtar M; Qadri F; Bhuiyan TR; Akter S; Rafique TA; Khan A; Islam LN; Saha A; Svennerholm AM; Lundgren A
Vaccine; 2017 Jan; 35(2):321-328. PubMed ID: 27916412
[TBL] [Abstract][Full Text] [Related]
32. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.
Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Huda S; Huq MI; Holmgren J
Pediatr Infect Dis J; 1989 Feb; 8(2):105-9. PubMed ID: 2704600
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
Majumdar AS; Dutta P; Dutta D; Ghose AC
Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
[TBL] [Abstract][Full Text] [Related]
34. Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1.
Khan AI; Chowdhury F; Harris JB; Larocque RC; Faruque AS; Ryan ET; Calderwood SB; Qadri F
Scand J Infect Dis; 2010; 42(1):48-56. PubMed ID: 19883159
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
Chongsa-Nguan M; Chaicumpa W; Kalambaheti T; Surachedchai Y; Thanungkul B
Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
[TBL] [Abstract][Full Text] [Related]
36. Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection.
Nandy RK; Albert MJ; Ghose AC
Vaccine; 1996 Aug; 14(12):1137-42. PubMed ID: 8911010
[TBL] [Abstract][Full Text] [Related]
37. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
Snyder JD; Allegra DT; Levine MM; Craig JP; Feeley JC; DeWitt WE; Blake PA
J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
[TBL] [Abstract][Full Text] [Related]
38. Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.
Hossain M; Islam K; Kelly M; Mayo Smith LM; Charles RC; Weil AA; Bhuiyan TR; Kováč P; Xu P; Calderwood SB; Simon JK; Chen WH; Lock M; Lyon CE; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Leung DT; Azman AS; Harris JB; Qadri F; Ryan ET
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007874. PubMed ID: 31743334
[TBL] [Abstract][Full Text] [Related]
39. Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.
Chowdhury F; Akter A; Bhuiyan TR; Biswas R; Firoj MG; Tauheed I; Harris JB; Larocque RC; Ross AG; McMillan NAJ; Charles RC; Ryan ET; Calderwood SB; Qadri F
Front Immunol; 2022; 13():1067737. PubMed ID: 36618409
[TBL] [Abstract][Full Text] [Related]
40. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S
Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
